TCF7L2 and breast carcinoma: Therefore, we revealed that miR‐6882 is a new tumour suppressor‐miR in breast cancer that inhibits stemness characteristics through directly targeting TCF7L2 and further affecting the Wnt/β‐catenin signalling pathway.